Biological context {#Sec1}
==================

β-Phosphoglucomutase (βPGM, EC 5.4.2.6) from *Lactococcus lactis* is a magnesium-dependent phosphoryl transfer enzyme of the haloacid dehalogenase superfamily (Lahiri et al. [@CR16]; Allen and Dunaway-Mariano [@CR1]; Dai et al. [@CR9]). In the catabolism of maltose and trehalose, βPGM catalyses the reversible isomerisation of β-glucose 1-phosphate (βG1P) and glucose 6-phosphate (G6P). During catalysis, βG1P binds to phosphorylated βPGM (βPGM^P^, phosphorylated on residue D8) forming β-glucose 1,6-bisphosphate (βG16BP), which is released to solution. Subsequent rebinding of βG16BP in the alternate orientation to non-phosphorylated, substrate-free βPGM results in dephosphorylation of βG16BP, with the formation of G6P (which enters glycolysis) and the regeneration of βPGM^P^ (Zhang et al. [@CR29]; Dai et al. [@CR8]). The βPGM gene (*pgmB*) is located on the trehalose operon and is induced by maltose or trehalose in the growth medium but is repressed by the presence of glucose or lactose (Qian et al. [@CR22], [@CR23]). A βPGM knockout mutant strain of *L. lactis* shows impaired growth when maltose is used as the only carbon source, coupled with an intracellular accumulation of trehalose 6-phosphate and polysaccharide molecules composed of α-1,4-linked glucose units (Levander et al. [@CR20]). Such a perturbation of the metabolic flux highlights the crucial role that βPGM plays in mediating the efficient utilisation of carbohydrate species in *L. lactis* metabolism.

Wild-type βPGM (βPGM~WT~) together with a series of variants have been studied extensively using kinetic experiments (Zhang et al. [@CR29]; Dai et al. [@CR8], [@CR9]; Goličnik et al. [@CR12]), X-ray crystallography (Lahiri et al. [@CR16], [@CR17], [@CR18]; Tremblay et al. [@CR27]; Baxter et al. [@CR6]; Griffin et al. [@CR13]; Jin et al. [@CR14]; Johnson et al. [@CR15]), NMR spectroscopy (Baxter et al. [@CR3], [@CR4], [@CR5], [@CR6]; Griffin et al. [@CR13]; Jin et al. [@CR14]; Johnson et al. [@CR15]) and density functional theory approaches (Webster [@CR28]; Marcos et al. [@CR21], Elsässer et al. [@CR10]; Barrozo et al. [@CR2]) and it is considered as an archetypal system for enzyme catalysed phosphoryl transfer reactions. Structural analysis coupled with metal-fluoride ground state and transition state analogue (TSA) complexes have allowed the atomic resolution description of several discrete species found in the catalytic cycle i.e. substrate-free βPGM~WT~ (PDB: 2WHE; Baxter et al. [@CR6]), a ground state βPGM~WT~^P^ analogue (βPGM~WT~:BeF~3~ complex; PDB: 2WFA; Griffin et al. [@CR13]), two ground state βPGM~WT~^P^:G6P complexes (βPGM~WT~:BeF~3~:G6P complexes; PDB: 2WF8; PDB: 2WF9; Griffin et al. [@CR13]), two βPGM~D10N~:βG16BP complexes (PDB: 5OK1; PDB: 5OK0; Johnson et al. [@CR15]), a βPGM~WT~^P^:G6P TSA complex (βPGM~WT~:MgF~3~:G6P TSA complex; PDB: 2WF5; Baxter et al. [@CR6]) and a βPGM~WT~^P^:βG1P TSA complex (βPGM~WT~:MgF~3~:βG1CP TSA complex; PDB: 4C4R; Jin et al. [@CR14]). The enzyme active site is located in the cleft formed between the α/β core domain (M1--D15 and S88--K216) and the α-helical cap domain (T16--V87). During catalysis, domain reorientation through hinge residue (D15--T16 and V87--S88) rearrangement results in closure and opening of the active site cleft facilitating substrate binding and product release. Two phosphate group binding sites are present, one in a *proximal* site adjacent to the carboxylate nucleophile (residue D8) (Lahiri et al. [@CR16]) and the catalytic Mg^II^ ion (Lahiri et al. [@CR16]), and the other in a *distal* site located \~ 8 Å away in the closed enzyme (Lahiri et al. [@CR18]). The carboxylate group of the assigned general acid--base (residue D10) (Dai et al. [@CR9]) populates two orientations depending on the degree of active site closure. In the structures of substrate-free βPGM~WT~ and the βPGM~WT~^P^ analogue, the active site cleft is open and the D10 carboxylate group is not engaged in the active site, whereas in the closed βPGM~WT~^P^:G6P, βPGM~D10N~:βG16BP, βPGM~WT~^P^:G6P TSA and βPGM~WT~^P^:βG1P TSA complexes, the carboxylate group is positioned to facilitate general acid--base catalysis promoting phosphoryl transfer (Johnson et al. [@CR15]). Key roles for several residue segments in the active site have been identified including, coordination of the transferring phosphate group in the *proximal* site (V9, D10, S114, A115 and K145) (Lahiri et al. [@CR18]), coordination of the phosphate group of the substrate in the *distal* site (R49, S116, K117 and N118) (Lahiri et al. [@CR18]), substrate discrimination and binding (L44--L53) (Lahiri et al. [@CR19]) and coordination of the catalytic Mg^II^ ion (D10, E169 and D170) (Lahiri et al. [@CR16]).

Previously, the solution behaviour of substrate-free βPGM~WT~ was investigated by NMR spectroscopy and a backbone resonance assignment was determined (BMRB: 7235; Baxter et al. [@CR3]). However, 30 residues (D8--T16, R38, L44--L53, S114--N118, V141--A142, K145 and S171--Q172) located primarily in the active site loops remained unassigned in the ^1^H--^15^N TROSY spectrum, most likely due to extensive conformational intermediate exchange dynamics occurring on the millisecond timescale, which results in broadening of the correlations beyond the limits of detection. Substrate-free βPGM is an essential component of the catalytic cycle and an understanding of the dynamics of key residue segments would present significant insights into βPGM functionality. Accordingly, a series of single site variants of βPGM was screened to establish whether any improvement in spectral quality could be obtained. Of the variants tested, the P146A variant of βPGM (βPGM~P146A~) reduced the intermediate exchange dynamics by the strongest extent and so was investigated further. On the basis of the conformational properties of alanine, βPGM~P146A~ is expected to adopt a *trans* K145--A146 peptide bond as the dominant population. In contrast, all of the reported crystal structures described for βPGM~WT~, indicate a *cis* K145--P146 peptide bond within the D137--A147 loop. Consequently the isomerisation state of the 145--146 peptide bond presents a trigger for some of the intermediate exchange dynamics observed. Preliminary kinetics experiments using methods described previously (Johnson et al. [@CR15]) indicate that βPGM~P146A~ is active. Complete equilibration of 10 mM βG1P with G6P by 3 μM βPGM~P146A~ was achieved in 1.5 h. Here, we report the ^1^H~N~, ^15^N, ^13^C~α~, ^13^C~β~ and ^13^C' backbone resonance assignments of substrate-free βPGM~P146A~, including the resonances of many residues that were previously unassigned in substrate-free βPGM~WT~.

Methods and experiments {#Sec2}
=======================

Protein expression and purification {#Sec3}
-----------------------------------

Site-directed mutagenesis (QuikChange II Site-Directed Mutagenesis Kit, Agilent Technologies) of the *pgmB* from *Lactococcus lactis* cloned in the pET-22b(+) expression plasmid was employed to generate βPGM~P146A~ using primers with single-site base changes. Successful mutagenesis was confirmed by DNA sequencing. The plasmid was transformed into *Escherichia coli* strain BL21(DE3) cells (Stratagene) and ^2^H,^15^N,^13^C-labelled βPGM~P146A~ (25 kDa) was expressed in defined isotopically labelled minimal media (Reed et al. [@CR24]). The cells were grown at 37 °C with shaking until OD~600nm~ = 0.6, at which point they were cooled to 25 °C and induced with isopropyl β-[d]{.smallcaps}-1-thiogalactopyranoside (IPTG) to a final concentration of 0.5 mM. Cells were incubated for a further 18 h and were harvested by centrifugation at 10,000 rpm for 10 min. The cell pellet was resuspended in ice-cold standard working buffer (50 mM K^+^ HEPES pH 7.2, 5 mM MgCl~2~, 2 mM NaN~3~, 1 mM EDTA) supplemented with cOmplete™ protease inhibitor cocktail (Roche) (one tablet per 50 mL cell suspension). The cell suspension was lysed on ice using 6 cycles of sonication with pulsation for 20 s followed by 60 s cooling intervals. The cell lysate was then separated by ultracentrifugation at 20,000 rpm (Beckman Coulter Avanti centrifuge using rotor JA-20) for 35 min at 4 °C. The cleared cell lysate was filtered using a 0.22 µm syringe filter (Merck Millipore) and loaded onto a DEAE-Sepharose fast flow anion-exchange column connected to an ÄKTA purification system (GE Healthcare) that had been washed previously with 1 column volume of 6 M guanidine chloride, 1 column volume of 1 M NaOH and equilibrated with 5 column volumes of standard working buffer. Proteins bound to the DEAE-Sepharose column were eluted with a gradient of 0 to 50% standard working buffer containing 1 M NaCl. Fractions were checked for the presence of βPGM~P146A~ by SDS-PAGE, pooled together and concentrated by Vivaspin (10 kDa MWCO, Sartorius). The protein sample was loaded onto a prepacked Hiload 26/60 Superdex 75 size-exclusion column connected to an ÄKTA purification system previously washed with 1 column volume of 1 M NaOH and equilibrated with 1.5 column volumes of standard working buffer containing 1 M NaCl. Fractions containing βPGM~P146A~ were checked for purity by SDS-PAGE, pooled together and buffer exchanged into standard working buffer and concentrated to \~ 1.6 mM by Vivaspin (10 kDa MWCO) for storage as 1 mL aliquots at − 20 °C. No procedure was necessary to promote back exchange to amide protium atoms in perdeuterated βPGM~P146A~. Protein concentrations were estimated by absorbance at 280 nm (ε~280~ = 19940 M^−1^ cm^−1^). All reagents were of analytical grade and were purchased from Sigma-Aldrich (UK), except for the stable isotopically-labelled compounds ^15^NH~4~Cl (99%), ^13^C, ^2^H~7~-[d]{.smallcaps}-Glucose (U--^13^C~6~, 99%; 1,2,3,4,5,6,6-d~7~ 97--98%) and ^2^H~2~O (99.8%), which were purchased from CortecNet (France) and used as received.

NMR experiments {#Sec4}
---------------

The NMR experiments were acquired using samples loaded into 5-mm NMR tubes, which contained 1.2 mM ^2^H,^15^N,^13^C-labelled βPGM~P146A~ in standard working buffer supplemented with ^2^H~2~O (10% v/v) for the deuterium lock and 1 mM trimethylsilyl propanoic acid (TSP) as a chemical shift reference. All experiments were recorded at 298 K using an 800 MHz Bruker Avance I spectrometer fitted with a 5-mm TXI probe equipped with z-axis gradients and running TopSpin software version 2.1. For the backbone ^1^H, ^15^N, ^13^C resonance assignment of substrate-free βPGM~P146A~, 2D ^1^H--^15^N TROSY and TROSY-based 3D HNCA, HN(CO)CA, HNCACB, HN(CO)CACB, HN(CA)CO and HNCO spectra were acquired using standard Bruker pulse sequences. ^1^H chemical shifts were referenced relative to the internal TSP signal resonating at 0.0 ppm, whereas ^15^N and ^13^C chemical shifts were referenced indirectly using nuclei-specific gyromagnetic ratios.

Resonance assignments and data deposition {#Sec5}
=========================================

Backbone ^1^H~N~, ^15^N, ^13^C~α~, ^13^C~β~ and ^13^C' chemical shifts were assigned for substrate-free βPGM~P146A~ using standard triple resonance methodology (Gardner and Kay [@CR11]). The processing of spectra and peak picking were performed using FELIX (Felix NMR, Inc.). Frequency matching of the backbone assignments was achieved using a simulated annealing algorithm employed by the "asstools" assignment program (Reed et al. [@CR24]). The backbone ^1^H~N~, ^15^N, ^13^C~α~, ^13^C~β~ and ^13^C' chemical shifts have been deposited in the BioMagResBank (<http://www.bmrb.wisc.edu/>) under the BMRB accession code 27920. Excluding the nine proline residues and the N-terminal methionine residue, 194 out of a possible 211 residues were assigned in the ^1^H--^15^N TROSY spectrum (Fig. [1](#Fig1){ref-type="fig"}). In total, 93.4% of all backbone resonances were assigned (91.9% of ^1^H~N~, 91.9% of ^15^N, 94.6% of ^13^C~α~, 93.7% of ^13^C~β~ and 94.6% of ^13^C′ nuclei).Fig. 1^1^H--^15^N TROSY spectrum of ^2^H,^15^N,^13^C-labelled substrate-free βPGM~P146A~ in 50 mM K^+^ HEPES pH 7.2, 5 mM MgCl~2~, 2 mM NaN~3~, 1 mM EDTA, 10% v/v ^2^H~2~O and 1 mM TSP recorded on an 800 MHz spectrometer at 298 K. **a** The full spectrum is shown together with **b** an expansion of the crowded region. The assignments of the backbone amide resonances are indicated by residue type and sequence number

There are 17 residues that remain unassigned in the ^1^H--^15^N TROSY spectrum of substrate-free βPGM~P146A~ (L9, D10, G11, R38, L44, K45, G46, S48, R49, E50, D51, S52, L53, K117, N118, D170 and S171) compared with 30 residues in substrate-free βPGM~WT~ (Fig. [2](#Fig2){ref-type="fig"}). From the crystal structures of substrate-free βPGM~WT~ (PDB: 2WHE) and the βPGM~WT~:MgF~3~:G6P TSA complex (PDB: 2WF5), all of the unassigned residues in substrate-free βPGM~P146A~ (except for R38) are situated within the active site and have significant roles in the catalytic cycle of the enzyme. Residues L9, D10 and G11 are key components of the *proximal* site, with D8 identified as the nucleophile, D10 assigned as the general acid--base and residues D10, D170 and S171 comprising the catalytic Mg^II^ ion binding site. Residues R49, K117 and N118 coordinate the phosphate group of the substrate in the *distal* binding site and the active site loop L44--L53 in the cap domain comprises part of a helix--loop--helix motif and is involved in substrate discrimination and binding. Due to the involvement of these residue segments in the catalytic cycle, it is likely that conformational exchange dynamics between two (or more) similarly populated forms is still occurring on the millisecond timescale in substrate-free βPGM~P146A~, resulting in the attenuation of ^1^H--^15^N TROSY correlations beyond the limits of detection. Increased solvent exposure of the amide group of R38 through perturbation of hydrogen bonding with neighbouring sidechain groups may be coupled with helix-fraying exchange behaviour within the second α-helix (D37--E42) and the first turn of the third α-helix (S48--D58) of the cap domain, resulting in a loss of the ^1^H--^15^N TROSY correlation.Fig. 2Cartoon representation of the substrate-free βPGM~WT~ crystal structure (PDB: 2WHE) highlighting the extent of backbone amide resonance assignments for substrate-free βPGM~P146A~ and substrate-free βPGM~WT~. Assigned residues for βPGM~P146A~ are coloured white (for loops and α-helices) and tan (for β-strands), with proline residues coloured green and residues that were unassigned in βPGM~WT~ coloured cyan. Unassigned residues for βPGM~P146A~ (L9, D10, G11, R38, L44, K45, G46, S48, R49, E50, D51, S52, L53, K117, N118, D170 and S171) are coloured purple and the 30 unassigned residues for βPGM~WT~ are listed here for comparison (D8, L9, D10, G11, V12, I13, T14, D15, T16, R38, L44, K45, G46, V47, S48, R49, E50, D51, S52, L53, S114, A115, S116, K117, N118, V141, A142, K145, S171 and Q172). The location of the P146A mutation site is highlighted with a red backbone and the catalytic magnesium ion is shown as a green sphere

The secondary structure content and residue-specific random coil index order parameters (RCI-S^2^) of substrate-free βPGM~P146A~ were predicted by uploading the backbone ^1^H~N~, ^15^N, ^13^C~α~, ^13^C~β~ and ^13^C' chemical shifts to the TALOS-N webserver (Shen and Bax [@CR26]). The predicted secondary structure for the solution conformation of substrate-free βPGM~P146A~ compares well with the secondary structure present in the substrate-free βPGM~WT~ crystal (PDB: 2WHE) (Fig. [3](#Fig3){ref-type="fig"}). In addition, residues with the highest values of RCI-S^2^ are located in well-defined secondary structure elements, whereas residues with the lowest values (having more random coil-like chemical shifts) correspond to loop regions in the crystal structure. Together, these data are in very good agreement, which indicates that the solution conformation is similar to the protein structure observed in the substrate-free βPGM~WT~ crystal and provides confidence in the assignments of substrate-free βPGM~P146A~.Fig. 3Predicted secondary structure content and residue-specific random coil index order parameters (RCI-S^2^) of substrate-free βPGM~P146A~ obtained with the TALOS-N webserver (Shen and Bax [@CR26]) using the backbone ^1^H~N~, ^15^N, ^13^C~α~, ^13^C~β~ and ^13^C′ chemical shifts. The secondary structure prediction is shown as red bars for α-helices and blue bars for β-strands, with the height of the bars representing the probability assigned by the software. As a comparison, the secondary structure observed in the substrate-free βPGM~WT~ crystal (PDB: 2WHE) is shown at the top of the figure in the same colour representation. The predicted RCI-S^2^ values are shown as black circles

A chemical shift comparison between substrate-free βPGM~P146A~ and substrate-free βPGM~WT~ (BMRB: 7235; Baxter et al. [@CR3]) also supports the conclusion that the solution conformations of the two proteins are very similar. Negligible Δδ values are observed for all residues of the cap domain and small Δδ values are noted for the majority of residues present in the core domain (Fig. [4](#Fig4){ref-type="fig"}). However, some larger Δδ values (0.08 \< Δδ \< 1.65 ppm) are observed primarily for two contiguous residue segments (D133--A153 and G174--S181), which are located within \~ 8 Å of the P146A mutation site. For a conservative single site amino acid substitution in a protein, chemical shift perturbations caused by changes in the local chemical environment are usually restricted to the immediate vicinity (within \~ 4 Å) of the mutation site (Baxter et al. [@CR7]). Here, the size and the more widespread distribution of the chemical shift changes, together with a propagation of effects through several secondary structure elements, strongly suggest that the conformation of the D137--A147 loop is different in the two proteins. Conformational heterogeneity in this loop is observed when comparing crystal structures of substrate-free βPGM~WT~ (e.g. PDB: 1ZOL versus 2WHE; Zhang et al. [@CR29]; Baxter et al. [@CR6]). The source of this difference in structure is most probably associated with the isomerisation state of the K145--X146 peptide bond. For βPGM~WT~, all the reported crystal structures have a *cis* K145--P146 peptide bond and this isomer is also populated in solution as P146 δ^13^C~β~ = 34.8 ppm (Shen and Bax [@CR25]). For βPGM~P146A~, a regular *trans* K145--A146 peptide bond is adopted according to TALOS-N, as expected on the basis of the conformational properties of alanine.Fig. 4A chemical shift comparison between substrate-free βPGM~P146A~ and substrate-free βPGM~WT~. **a** Histogram of residue-specific chemical shift changes calculated between βPGM~P146A~ and βPGM~WT~ (BMRB: 7235; Baxter et al. [@CR3]) as Δδ~\|HN\ +\ 0.12\*N\|~ = \[Δδ~HN~^2^ + (0.12 × Δδ~N~)^2^\]^1/2^, where Δδ~X~ = δ~X:βPGM:P146A~ − δ~X:βPGM:WT~ and X = ^1^H~N~ or ^15^N nuclei of the backbone amide group. Secondary structure elements from substrate-free βPGM~WT~ (PDB: 2WHE) are indicated as bars for α-helices and arrows for β-strands at the top of the panel. Proline residues, the location of the P146A mutation site and unassigned residues in the ^1^H--^15^N TROSY spectra of βPGM~P146A~ and βPGM~WT~ are shown as green, red, purple and cyan rectangles, respectively at the top of the panel. **b** Structure of substrate-free βPGM~WT~ (PDB: 2WHE) with residues coloured according to Δδ~\|HN\ +\ 0.12\*N\|~ (Δδ~\|HN\ +\ 0.12\*N\|~ \> 0.08 ppm) with the intensity of colour and thickness of the backbone corresponding to larger values. The location of the P146A mutation site is highlighted with a red backbone and the catalytic magnesium ion is shown as a green sphere

In conclusion, the isomerisation state of the K145--X146 peptide bond appears to lead to a difference in the active site dynamics, where the *cis* conformation triggers millisecond exchange for residues of the hinge (V12--T16), the nucleophile (D8) and residues responsible for coordinating the transferring phosphate group in the *proximal* site (D8 and S114--S116), and residues of the D137--A147 loop (V141--A142 and K145). These occur in addition to millisecond dynamics for residues involved in the coordination of the catalytic Mg^II^ ion and for the L44--L53 loop responsible for substrate discrimination and binding.
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